AG001EFT

146939-27-7 | 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-

AG001EFT

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	146939-27-7
Catalog Number	AG001EFT(AGN-PC-0PZJWC)
Chemical Name	2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-
EC Number	928-541-6
IUPAC Name	5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
InChI	InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)
InChI Key	MVWVFYHBGMAFLY-UHFFFAOYSA-N
MDL Number	MFCD00866661
Molecular Formula	C21H21ClN4OS
Molecular Weight	412.9356
SMILES	S1N=C(C2=C1C=CC=C2)N2CCN(CC2)CCC=2C=C1CC(NC1=CC2Cl)=O
UNII	6UKA5VEJ6X
Synonyms	5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, CP 88059, CP 88059-01, CP-88,059, CP-88,059-01, CP-88,059-1, Geodon, ziprasidone, ziprasidone hydrochloride, ziprasidone hydrochloride, monohydrate, ziprazidone, Ziprasidone, 146939-27-7, Geodon, Zeldox, Ziprasidone hydrochloride, Ziprasidone [INN:BAN], UNII-6UKA5VEJ6X, CP 88059, 6UKA5VEJ6X, Ziprasidone mesylate trihydrate, CHEMBL708, C21H21ClN4OS, CHEBI:10119, CP-88,059-1, ziprazidone, DSSTox_CID_3753, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one, DSSTox_RID_77186, DSSTox_GSID_23753, 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, ziprasidona, ziprasidonum, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one, 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one, Zipradon (TN), 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Ziprasidone (INN), CAS-146939-27-7, NCGC00186050-01, CP-880591, CP-8805927, CP-88059-27, CP-88,059, Geodon Oral, CP 88059-01, HSDB 7745, CP-88,059-01, GTPL59, C07568, SCHEMBL28028, MLS000759435, BIDD:GT0042, AC1L1U27, DTXSID4023753, MVWVFYHBGMAFLY-UHFFFAOYSA-N, ZINC538550, Tox21_112194, Tox21_113525, 4169AH, BDBM50048803, CZ0013, AKOS015900383, Tox21_112194_1, AM90310, API0004647, CS-1071, DB00246, 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, NCGC00263539-01, NCGC00263539-03, NCGC00263539-05, AC-23360, AJ-23401, AN-16930, BC643069, CPD000466328, HY-14542, LS-83744, SAM001246607, SC-22049, SMR000466328, TL8000889, FT-0654208, FT-0655916, VU0286234-2, 4770-EP2272537A2, 4770-EP2272841A1, 4770-EP2275420A1, 4770-EP2280010A2, 4770-EP2298731A1, 4770-EP2298776A1, 4770-EP2301936A1, 4770-EP2308875A1, 4770-EP2316836A1, D08687, W-5149, AB00639925-02, AB00639925-04, AB00639925_05, AB00639925_06, 883Z936, A808568, L000659, CP 88059;CP-88059;CP88059, I14-0766, 122883-93-6,138982-67-9(ClH.H2O),146939-27-7(freebase), 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one, 5-[2-[4-(1,2-benzothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydroindol-2-one, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloranyl-1,3-dihydroindol-2-one, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one, 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone), 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole), 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one, Ziprasidone solution, 1.0 mg/mL in 1,2-dimethoxyethane, ampule of 1 mL, certified reference material, Ziprasidone HCl, zaprasidone, Zipradon, Ziprasidone-d8, Ziprasidone mesilate, Ziprasidone mesylate, Geodon (TN), Zeldox (TN), D0E0NJ, D0R1JV, C21-H21-Cl-N4-O-S, CP-88059, CID60854, ziprasidone hydrochloride, monohydrate, TC-5280, NCGC00164565-01, 2809B, CP-88059-1, Z0034, A15286, C092292, 138982-67-9, 122883-93-6, 5-(2-(4-(1,2-benzisothiazol-3-yl)piperazinyl)ethyl)-6-chlorooxindole, 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, 6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one,

Complexity	573
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	412.112g/mol
Formal Charge	0
Heavy Atom Count	28
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	412.936g/mol
Monoisotopic Mass	412.112g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	76.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H335
Packing Group
Precautionary statements	P261
UN Code

Certificate of Analysis

Lot Number